Efficacy and safety of methylprednisolone against acute respiratory distress syndrome: A systematic review and meta-analysis

BACKGROUND: Acute respiratory distress syndrome (ARDS) is caused by an inflammatory injury to the lung. Dysregulated inflammation is the cardinal feature of ARDS. Methylprednisolone is an option for treating ARDS. However, the benefits and adverse effects of methylprednisolone have not been well ass...

Descripción completa

Detalles Bibliográficos
Autores principales: Lv, Hai, Dai, Linfeng, Lu, Jun, Cheng, Lu, Geng, Yanxia, Chen, Mingqi, Chen, Qiuhua, Wang, Xing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2021
Materias:
6700
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8036107/
https://www.ncbi.nlm.nih.gov/pubmed/33832136
http://dx.doi.org/10.1097/MD.0000000000025408

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8036107/
https://www.ncbi.nlm.nih.gov/pubmed/33832136
http://dx.doi.org/10.1097/MD.0000000000025408

Ejemplares similares